–
Maze Therapeutics, Inc.
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−111
FY23:
−98.6
FY24:
57.6
FY25:
−143
(positive)
Change from FY22 to FY25
millions USD
FY22:
−105
FY23:
−94.5
FY24:
60.9
FY25:
−140
(positive)
Change from FY22 to FY25
millions USD
FY22:
−115
FY23:
−100
FY24:
53.4
FY25:
−131
(positive)
Change from FY22 to FY25
millions USD
FY22:
−115
FY23:
−100
FY24:
52.2
FY25:
−131
All amounts in millions USD FY22, FY23: figures supplemented from Twelve Data because the SEC filings do not reach back this far.